As more plaintiffs file lawsuits, Mounjaro has become a major focus in the ongoing Ozempic litigation MDL
Acknowledgements We thank L MHamdi and L Puydenus from SBEC-BEC (Support Biopathologique aux Etudes Cliniques - Bureau des Etudes Cliniques) from Institut Claudius Regaud-IUCT-Oncopole for TMAs and technical support
Reczek CR, Chandel NS (2017) The two faces of reactive oxygen species in cancer
Factors such as age, genetics, and previous weight fluctuations can make the problem worse
A study suggested also that the use of a BP-lowering central sympatholytic drug, moxonidine, might induce a small but significant weight loss, together with a reduction in blood pressure, triglycerides and fasting blood glucose (Chazova and Schlaich, 2013), though another study failed to demonstrate any impact on insulin sensitivity (Masajtis-Zagajewska et al., 2010)